−£150k
vs Dec 2023Active02460338Private limited companyNuneaton
BHR PHARMACEUTICALS LIMITED
Significant control: Biosynex S.A (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Bhr Pharmaceuticals Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Bhr Pharmaceuticals Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
BHR PHARMACEUTICALS LIMITED is an active private limited company (company number 02460338) incorporated on 17 January 1990, registered in Nuneaton. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest small accounts cover the period ending 31 December 2024, showing net assets of −£150k and cash of £409k, with 18 employees on average. Net assets rose 21% on the prior period (−£190k).
Peer position · net assets
By net assets it sits in the bottom quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).
02
Ownership and control
- Biosynex S.A
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Rameshkumar Jerambhai Patel
- owns 50–75% of shares
- holds 50–75% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 17 January 199036 yrs ago
- Next accounts due
- 30 September 202625 days overdue
- Confirmation statement due
- 31 January 2027in 98 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
05
Financials
£409k
−45%vs Dec 2023Not reported
18
−5%vs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£150k | £409k | £457k | — | — | — | 18 |
| 31 December 2023 | −£190k | £742k | £404k | — | — | — | 19 |
Cash per employee£23kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-149,564 at 31 December 2024
- Net assets up 10% or more on the prior period+21.4% vs prior period
- Cash at bank of £50,000 or moreCash £408,951
- Incorporated five or more years agoIncorporated 17 January 1990
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 98 days
- Next accounts due25 days overdue
- Accounts period endNet liabilities £150k · small accounts
- Accounts period endNet liabilities £190k · small accounts
- Incorporated
08
Similar companies in Coventry
- MANX HEALTHCARE LIMITEDWarwick · inc. Mar 1994
- MANX PHARMA LTDWarwick · inc. Sept 1996
- DURJA PHARMA LIMITEDRugby · inc. Dec 2014
- SG FOODS U.K LTDCoventry · inc. Apr 2016
- ACETHERIX HEALTHCARE LTDCoventry · inc. Dec 2021
- THUBTON PHARMA LTDCoventry · inc. Apr 2023
All companies incorporated on 17 January 1990 · in Jan 1990.
09
Reminders for BHR PHARMACEUTICALS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.